We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

New Radiotherapy Technique Shown to Be Safe for Cancer Patients

By MedImaging International staff writers
Posted on 07 Jul 2009
A new technique, known as stereotactic body radiotherapy (SBRT), is safe for patients with recurrent head and neck cancers, and may improve their quality of life, according to researchers.

The investigators, from the University of Pittsburgh Cancer Institute (UPCI; PA, USA), presented findings of their phase I study June 17, 2009, in the International Journal of Radiation Oncology, Biology, Physics.

Each year approximately 500,000 cases of squamous cell carcinoma of the head and neck are diagnosed worldwide. While treatment has improved with advances in surgery, radiation, and chemotherapy, more than half of patients will die from recurrent disease. Treatment options for patients with recurrent disease are limited, and for many, surgery may not be an option, according to lead investigator Dwight E. Heron, M.D., director, Radiation Oncology Services, University of Pittsburgh Medical Center (UPMC) Cancer Centers.

"Chemotherapy alone can provide this patient population some palliation and pain relief, but it doesn't prolong survival,” said Dr. Heron. "A few patients may be able to receive additional radiation treatments, but head and neck cancers, by their very nature, develop in very delicate areas of the body, which provide significant retreatment challenges.”

SBRT may offer these patients an alternative, noted Dr. Heron. "At the completion of our study, we found this treatment was tolerated very well. No maximum tolerated dose was reached, and no toxicities occurred that caused us to limit the dosing.”

SBRT is a comparatively new technique using CyberKnife technology, which delivers high doses of radiation with more precision than traditional techniques. The vast majority of patients complete treatment within 10 days. In the trial, 31 patients with recurrent, inoperable head and neck cancers were treated over a two-week period. Positron emission tomography- (PET)-CT also was used to develop a customized radiation treatment plan for each patient, allowing radiation oncologists to target the cancer more accurately while sparing healthy tissue.

"Ultimately, SBRT offers patients a better quality of life. Instead of having to go through six or seven weeks of treatments that are often associated with significant toxicities, patients can receive treatment over a shorter course and still get the same outcomes compared to the current standard of care,” said Dr. Heron.

Related Links:

University of Pittsburgh Cancer Institute




Digital Radiographic System
OMNERA 300M
40/80-Slice CT System
uCT 528
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Multi-Use Ultrasound Table
Clinton

Latest Radiography News

AI Detects Fatty Liver Disease from Chest X-Rays
07 Jul 2009  |   Radiography

AI Detects Hidden Heart Disease in Existing CT Chest Scans
07 Jul 2009  |   Radiography

Ultra-Lightweight AI Model Runs Without GPU to Break Barriers in Lung Cancer Diagnosis
07 Jul 2009  |   Radiography